Nathan Hardy
Directeur Financier/CFO chez SANA BIOTECHNOLOGY, INC.
Fortune : 3 M $ au 30/06/2024
Profil
Nathan Hardy's career history includes serving as the Chief Financial Officer & Executive Vice President at Sana Biotechnology, Inc. He previously worked at Amgen, Inc. as the Executive Director & Head-Corporate Finance from 2007 to 2017.
Prior to that, he was the Vice President-Finance at Juno Therapeutics, Inc. from 2017 to 2018.
Mr. Hardy holds an MBA from the University of Notre Dame and an undergraduate degree from the University of Utah.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SANA BIOTECHNOLOGY, INC.
0,23% | 01/04/2024 | 514 713 ( 0,23% ) | 3 M $ | 30/06/2024 |
Postes actifs de Nathan Hardy
| Sociétés | Poste | Début |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Directeur Financier/CFO | 01/09/2018 |
Anciens postes connus de Nathan Hardy
| Sociétés | Poste | Fin |
|---|---|---|
| JUNO THERAPEUTICS INC | Directeur Financier/CFO | 01/06/2018 |
| AMGEN INC. | Directeur/Membre du Conseil | 01/08/2017 |
Formation de Nathan Hardy
| University of Utah | Undergraduate Degree |
| University of Notre Dame | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
